๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Splenic tuberculosis in a patient with Crohn's disease on infliximab: Case report

โœ Scribed by Maria Cappello; Claudia Randazzo; Giulia Rizzuto; Celestino Bonura; Gaetano Di Vita; Massimo Galia


Publisher
John Wiley and Sons
Year
2010
Tongue
English
Weight
255 KB
Volume
16
Category
Article
ISSN
1078-0998

No coin nor oath required. For personal study only.

โœฆ Synopsis


FIGURE 1. MRI of the spleen. a: T1-weighted image on dynamic contrast-enhancement (axial). b: T1-weighted image on dynamic contrast-enhancement (coronal).


๐Ÿ“œ SIMILAR VOLUMES


Salmonella septic arthritis in a patient
โœ Jean Y. Rim; Allan R. Tenorio ๐Ÿ“‚ Article ๐Ÿ“… 2010 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 56 KB ๐Ÿ‘ 1 views

The use of tumor necrosis factor a (TNFa) inhibitors such as infliximab, etanercept, and adalimumab for various autoimmune diseases, including Crohn's disease (CD) and ulcerative colitis (UC), has increased in the past few years. While associated with symptomatic relief in many patients, the use of

Splenic function and IgM-memory B cells
โœ Antonio Di Sabatino; M. Manuela Rosado; Paolo Cazzola; Paolo Biancheri; Francesc ๐Ÿ“‚ Article ๐Ÿ“… 2008 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 308 KB ๐Ÿ‘ 1 views

Background: Under experimental chronic inflammation, tumor necrosis factor (TNF)-โฃ plays a role in damaging spleen marginal zone. This latter has a crucial function in mounting B cell-dependent immune responses against infections by encapsulated bacteria. In Crohn's disease (CD), a chronic inflammat